Changchun High-Tech Industry Group Co

Changchun High-Tech Industry Group Co EBIT Margin

The EBIT Margin (Operating Margin) of Changchun High-Tech Industry Group Co (000661.SZ) as of Nov 2, 2026 is 7.20 %. In the previous year, EBIT Margin (Operating Margin) was 24.48 % — a change of -70.57% (lower).

EBIT Margin

7.20 %

YoY

-70.57%

Last updated:

EBIT Margin (Operating Margin) of Changchun High-Tech Industry Group Co is 2025 7.20 % . EBIT Margin (Operating Margin) of Changchun High-Tech Industry Group Co was 2024 24.48 % . It decreases by -70.57% lower compared to the previous year.

For Changchun High-Tech Industry Group Co, the operating (EBIT) margin of 7.2% is down versus 43.9% a few years ago.

The Changchun High-Tech Industry Group Co EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
33.61 CNY
Jan 1, 2019
39.01 CNY
Jan 1, 2020
45.89 CNY
Jan 1, 2021
43.88 CNY
Jan 1, 2022
39.34 CNY
Jan 1, 2023
38.36 CNY
Jan 1, 2024
24.48 CNY
Jan 1, 2025
7.20 CNY
The Changchun High-Tech Industry Group Co EBIT Margin history
YEAREBIT MarginYoY
7.20 %-70.57%
24.48 %-36.20%
38.36 %-2.49%
39.34 %-10.34%
43.88 %-4.39%
45.89 %+17.65%
39.01 %+16.06%
33.61 %+20.93%
27.79 %-0.67%
27.98 %+7.63%
26.00 %+9.56%
23.73 %+8,707.27%
0.27 %+0.03%
0.27 %+62.36%
0.17 %-12.59%
0.19 %-12.42%
0.22 %+171.24%
0.08 %-39.77%
0.13 %+135.57%
0.06 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Changchun High-Tech Industry Group Co Stock analysis

What does Changchun High-Tech Industry Group Co do? Changchun High & New Technology Industries (Group), Inc. generates revenue through the research, development, production, and sale of biopharmaceuticals and proprietary Chinese medicines. Key products include polyethylene glycol recombinant human growth hormone injection, recombinant human growth hormone, recombinant human follicle stimulating hormone for injection, freeze-dried live attenuated varicella vaccines, and rabies vaccines for human use. The company also derives income from real estate development and property management services. Its primary market is domestic, serving customers within China who require pharmaceutical solutions and real estate services. The firm's biopharmaceutical segment focuses on innovative treatments such as growth hormone therapies and vaccines, targeting healthcare providers and consumers seeking advanced medical solutions. Real estate activities involve developing and managing properties, catering to residential and commercial clients in the domestic market. All operations are conducted within China, with no international expansion mentioned in the business description. Changchun High & New Technology Industries (Group), Inc. leverages its 8,841 full-time employees to support both pharmaceutical and real estate divisions. The company's product portfolio emphasizes high-demand medical treatments, including injectable growth hormones and vaccines, which are sold to domestic healthcare institutions and end-users. Real estate services complement the core business by providing additional revenue streams through property management and development. Changchun High-Tech Industry Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Changchun High-Tech Industry Group Co stock

EBIT Margin (Operating Margin) of Changchun High-Tech Industry Group Co is 7.20 % in 2025.

EBIT Margin (Operating Margin) of Changchun High-Tech Industry Group Co changed from 24.48 % to 7.20 %, representing a -70.57% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Changchun High-Tech Industry Group Co since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Changchun High-Tech Industry Group Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Changchun High-Tech Industry Group Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Changchun High-Tech Industry Group Co